Abstract: Provided is an apparatus for heating plastic parisons, including a transport device or transporter, which transports the plastic parisons at least in sections along a predefined transport path, wherein the transport device or transporter has a plurality of holding devices or holders for holding the plastic parisons, with a heating device or heaters for heating the plastic parisons at least at times, while they are being transported by the transport device or transporters, wherein the apparatus has at least one heat shielding device or heat shield which is suitable and intended to counteract the heating of mouth regions of the plastic parisons.

Abstract: Provided is an apparatus for heating plastic parisons, including a transport device or transporter, which transports the plastic parisons at least in sections along a predefined transport path, wherein the transport device or transporter has a plurality of holding devices or holders for holding the plastic parisons, with a heating device or heaters for heating the plastic parisons at least at times, while they are being transported by the transport device or transporters, wherein the apparatus has at least one heat shielding device or heat shield which is suitable and intended to counteract the heating of mouth regions of the plastic parisons.

Abstract: An apparatus for producing plastic containers is provided, comprising a heating device that heats plastic preforms, and including a shaping device provided downstream of this heating device in the transport direction of the plastic preforms, which shaping device shapes the plastic preforms into the plastic containers, wherein a tempering device for tempering the plastic preforms heated by the heating device is provided in the transport direction of the plastic preforms between the heating device and the shaping device, which tempering device has at least one tempering unit provided on a carrier rotatable about a predetermined rotary axis, and which tempering unit has at least two contacting devices, between which at least one section of the plastic preform can be received, which contacting devices can be moved in relation to one another along a predetermined direction.

Abstract: An apparatus for producing plastic containers is provided, comprising a heating device that heats plastic preforms, and including a shaping device provided downstream of this heating device in the transport direction of the plastic preforms, which shaping device shapes the plastic preforms into the plastic containers, wherein a tempering device for tempering the plastic preforms heated by the heating device is provided in the transport direction of the plastic preforms between the heating device and the shaping device, which tempering device has at least one tempering unit provided on a carrier rotatable about a predetermined rotary axis, and which tempering unit has at least two contacting devices, between which at least one section of the plastic preform can be received, which contacting devices can be moved in relation to one another along a predetermined direction.

Abstract: An apparatus is provided for producing plastic containers, comprising a heating device that heats plastic preforms, and including a shaping device provided downstream of this heating device in the transport direction of the plastic preforms, which shaping device shapes the plastic preforms into the plastic containers, wherein a tempering device for tempering the plastic preforms heated by the heating device is provided in the transport direction of the plastic preforms between the heating device and the shaping device, which tempering device has at least one tempering unit provided on a carrier rotatable about a predetermined rotary axis, and which tempering unit has at least two contacting devices, between which at least one section of the plastic preform can be received, which contacting devices can be moved in relation to one another along a predetermined direction.

Abstract: The invention relates to the use of implantable microcapsules, or microparticles or gels produced from alginates that are crosslinked with bivalent or multivalent cations or that are uncrosslinked, for the treatment of skin defects such as e.g. wrinkles, for the treatment of gastro-oesophageal reflux, urinary incontinence and vesico-ureteral reflux.

Abstract: A method of making and using a monolithic alginate implant is described. The implant is formed by providing an uncrosslinked, highly pure and high molecular weight alginate solution and injecting the alginate solution into a patient at a predetermined site to form a gel body comprising the monolithic alginate implant. Spontaneous crosslinking of the monolithic alginate implant occurs at the predetermined site without the addition of an exogenous crosslinker. The implant may be used for treating medical conditions requiring support of sphincter musculature, reconstructive surgery, or cosmetic reconstruction, for the treatment of wrinkles on the hand, face, or décolleté, or for increasing volume, for example in the case of (HIV-induced) lipoatrophy of the breasts, and for the treatment of selected diseases, including gastrooesophageal reflux disease, urinary incontinence or vesicoureteral reflux disease.

Abstract: The invention relates to a device for the molecular integration or disintegration of solid, liquid and/or gaseous flowing, entrained and/or countercurrent components by means of cavitation in order to modify, build or disintegrate molecular compounds. The invention allows to obtain stable mixtures from immiscible or difficult-to-mix components or to separate such mixtures. The supercavitation molecular reactor allows to build up or disintegrate or modify, with low expenditure in terms of energy, even complex compounds that so far have not been accessible to modification and/or production or only by very extensive multiple processes and a large amount of technical complexity.

Abstract: The invention relates to the use of implantable microcapsules, or microparticles or gels produced from alginates that are crosslinked with bivalent or multivalent cations or that are uncrosslinked, for the treatment of skin defects such as e.g. wrinkles, for the treatment of gastro-oesophageal reflux, urinary incontinence and vesico-ureteral reflux.

Abstract: Powdered or granulated enzyme preparations, free of surface active agents and containing a protease as the active enzyme, wherein the protease is present as a tannin complex, with the proviso that the enzyme preparation consists of at least 50 percent by weight and up to 99.9 percent by weight of one or more conventional diluent salts. Methods for soaking and bating skins and hides using such preparations.

Abstract: The content of phosphorus-containing components and the iron content of an edible vegetable or animal oil, preferably an oil such as soybean oil which has been wet-refined to remove mucilage, are reduced by enzymatic decomposition by contacting the oil with an aqueous solution of phospholipases A.sub.1, A.sub.2, or B and then separating the aqueous phase from the treated oil.

Abstract: A method for making a stable aqueous liquid formulation containing at least one enzyme having proteolytic activity is disclosed. The method involves precipitating the enzyme from an aqueous medium with a salt to form a dispersion of the enzyme. The dispersion has a density of 1.22 g/cm.sup.3 to 1.23 g/cm.sup.3 due to the use of the salt. This process yields a sedimentation-resistant stable enzyme dispersion.

Abstract: In a process for imidizing an alkyl methacrylate polymer by reaction with a nitrogen-containing imidizing agent, the formation of carboxyl and anhydride groups is suppressed when a portion of the imidizing agent is added only after the previously added imidizing agent has been reacted at least partially, and particularly when the reaction with the imidizing agent is terminated before the polymer has been completely imidized.

Abstract: There is presented compounds of the formula ##STR1## wherein X represents the 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl group or its corresponding tautomeric form, the 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl group, and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of the compounds and hydrates of the compounds of formula I or of their esters, ethers and salts. Also provided is a method of their manufacture and intermediates therefor as well as corresponding pharmaceutical preparations.

Abstract: There are presented compounds of the formula ##STR1## wherein R.sup.1 is one of the 3-substituents usable in cephalosporin chemistry, R.sup.2 is hydrogen, lower alkyl or COOR.sup.3 -lower alkyl, wherein R.sup.3 is hydrogen, a cation of a base or a readily hydrolyzable ester group, and X is sulphur, oxygen or one of the groups --SO-- and --SO.sub.2 --, and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of these compounds and hydrates of the compounds of formula I or of their esters, ethers and salts, also presented are methods for the manufacture of these compounds as well as compounds used in their manufacture.

Abstract: Polymers formed by incomplete esterification of the hydroxy groups of a water-soluble polymer such as polyvinyl alcohol, amylose or dextran with a pharmacologically acceptable mono- or di-carboxylic acid to an extent sufficient to render the polymer water-insoluble although still water-swellable, are biodegradable. They are useful for the formulation of pharmaceutical compositions for parenteral administration, particularly in the form of injectable fine particles in which a drug is intimately mixed with or encapsulated by the polymer.

Abstract: There are presented compounds of the formula ##STR1## wherein R.sup.1 is one of the 3-substituents usable in cephalosporin chemistry, R.sup.2 is hydrogen, lower alkyl or COOR.sup.3 -lower alkyl, wherein R.sup.3 is hydrogen, a cation of a base or a readily hydrolyzable ester group, and X is sulphur, oxygen or one of the groups --SO-- and --SO.sub.2 --,and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of these compounds and hydrates of the compounds of formula I or of their esters, ethers and salts, also presented are methods for the manufacture of these compounds as well as compounds used in their manufacture.

Abstract: There is presented compounds of the formula ##STR1## wherein X represents the 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl group or its corresponding tautomeric form, the 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl group,and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of the compounds and hydrates of the compounds of formula I or of their esters, ethers and salts. Also provided is a method of their manufacture and intermediates therefor as well as corresponding pharmaceutical preparations.

Abstract: There are presented compounds of the formula ##STR1## wherein R.sup.1 is one of the 3-substituents usable in cephalosporin chemistry, R.sup.2 is hydrogen, lower alkyl or COOR.sup.3 -lower alkyl, wherein R.sup.3 is hydrogen, a cation of a base or a readily hydrolyzable ester group, and X is sulphur, oxygen or one of the groups --SO-- and --SO.sub.2 --, and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of these compounds and hydrates of the compounds of formula I or of their esters, ethers and salts, also presented are methods for the manufacture of these compounds as well as compounds used in their manufacture.

Abstract: Polymers formed by incomplete esterification of the hydroxy groups of a water-soluble polymer such as polyvinyl alcohol, amylose or dextran with a pharmacologically acceptable mono- or di-carboxylic acid to an extent sufficient to render the polymer water-insoluble although still water-swellable, are biodegradable. They are useful for the formulation of pharmaceutical compositions for parenteral administration, particularly in the form of injectable fine particles in which a drug is intimately mixed with or encapsulated by the polymer.